Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionNegative allosteric modulator of GABA A receptor alpha 5 (GABRA5)
Molecular Target GABA A receptor alpha 5 (GABRA5)
Mechanism of ActionGABA A receptor modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCognitive dysfunction
Indication DetailsTreat cognitive and behavioral deficits associated with Down syndrome; Treat cognitive dysfunction associated with Down syndrome
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today